Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VRXA · against 1,372 other Healthcare companies
Ranked #637 of 1,373 · scores higher than 54% of peers · safety percentile 54
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 50–59, including VRXA · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VRXA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | Not reported | 0.24× | — | — | 33% |
| BetaLower is better · 1,320 reported | 0.18 | 0.53 | 80% | 33% | |
| Current ratioHigher is better · 1,338 reported | 0.44× | 2.62× | 1% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 633 | 14.8B CNY (≈$2.1B) | 54 | 23 | |
| 634 | 4.4B CNY (≈$621M) | 54 | 65 | |
| 635 | 7.2B CNY (≈$1.0B) | 54 | 44 | |
| 636 | 3.2B CNY (≈$451M) | 54 | 60 | |
| 637 | 140M USD | 54 | ||
| 638 | 17.8B CNY (≈$2.5B) | 54 | 39 | |
| 639 | 1.17T JPY (≈$8.0B) | 53 | 58 | |
| 640 | 311.5B THB (≈$8.7B) | 53 | 62 | |
| 641 | 1.7B USD | 53 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score